|
| 37962376 | JASPAR 2024: 20th anniversary of the open-access database of transcription factor binding profiles. | Nucleic Acids Res | 2024 |
| 36251678 | Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway. | Cancer Rep (Hoboken) | 2023 |
| 37627152 | A Breast Cancer Polygenic Risk Score Is Feasible for Risk Stratification in the Norwegian Population. | Cancers (Basel) | 2023 |
| 37622176 | Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential. | Mol Oncol | 2023 |
| 37181409 | Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database. | EClinicalMedicine | 2023 |
| 37467208 | hGSuite HyperBrowser: A web-based toolkit for hierarchical metadata-informed analysis of genomic tracks. | PLoS One | 2023 |
| 36608656 | The genetic history of Scandinavia from the Roman Iron Age to the present. | Cell | 2023 |
| 36573326 | screenwerk: a modular tool for the design and analysis of drug combination screens. | Bioinformatics | 2023 |
| 35047825 | A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer. | NAR Cancer | 2022 |
| 35841045 | Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway. | J Transl Med | 2022 |
| 35613827 | Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials. | J Immunother Cancer | 2022 |
| 35643867 | Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence. | Leukemia | 2022 |
| 36428697 | Genetic Characterization in High-Risk Individuals from a Low-Resource City of Peru. | Cancers (Basel) | 2022 |
| 36523963 | Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines. | Front Oncol | 2022 |
| 36182700 | The population genomic legacy of the second plague pandemic. | Curr Biol | 2022 |
| 36163057 | Functional precision cancer medicine: drug sensitivity screening enabled by cell culture models. | Trends Pharmacol Sci | 2022 |
| 36089578 | Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination. | J Transl Med | 2022 |
| 35948919 | Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy. | Genome Med | 2022 |
| 34850127 | MirGeneDB 2.1: toward a complete sampling of all major animal phyla. | Nucleic Acids Res | 2022 |
| 33257847 | Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report. | Genet Med | 2021 |
| 33743481 | Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report. | Eur J Cancer | 2021 |
| 33574832 | Editorial: Genomic Colocalization and Enrichment Analyses. | Front Genet | 2021 |
| 33922147 | The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology. | J Pers Med | 2021 |
| 34046035 | Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial. | Front Immunol | 2021 |
| 34249331 | Recommendations for the FAIRification of genomic track metadata. | F1000Res | 2021 |
| 34290704 | Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential. | Front Immunol | 2021 |
| 34203177 | No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in <i>MLH1</i> and <i>MSH2</i>: A Prospective Lynch Syndrome Database Study. | J Clin Med | 2021 |
| 34310709 | Cancer Predisposition Sequencing Reporter (CPSR): A flexible variant report engine for high-throughput germline screening in cancer. | Int J Cancer | 2021 |
| 34002043 | The genetic structure of Norway. | Eur J Hum Genet | 2021 |
| 31337882 | Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. | Genet Med | 2020 |
| 34367618 | The ELIXIR Human Copy Number Variations Community: building bioinformatics infrastructure for research. | F1000Res | 2020 |
| 31642479 | MirGeneDB 2.0: the metazoan microRNA complement. | Nucleic Acids Res | 2020 |
| 31927437 | Computational approaches in cancer multidrug resistance research: Identification of potential biomarkers, drug targets and drug-target interactions. | Drug Resist Updat | 2020 |
| 32050665 | Correction: Møller, P.; et al. Causes for Frequent Pathogenic <i>BRCA1</i> Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. <i>Cancers</i> 2019, <i>11</i>, 132. | Cancers (Basel) | 2020 |
| 33214604 | Accuracy and efficiency of germline variant calling pipelines for human genome data. | Sci Rep | 2020 |
| 32690931 | Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. | Genet Med | 2020 |
| 32605315 | Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes. | Cancers (Basel) | 2020 |
| 32939053 | Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status. | Br J Cancer | 2020 |
| 32365348 | Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors. | JCI Insight | 2020 |
| 32332858 | Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models. | Commun Biol | 2020 |
| 32208873 | Molecularly matched therapy in the context of sensitivity, resistance, and safety; patient outcomes in end-stage cancer - the MetAction study. | Acta Oncol | 2020 |
| 32374878 | Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series. | Blood Adv | 2020 |
| 31598695 | MirGeneDB 2.0: the metazoan microRNA complement. | Nucleic Acids Res | 2020 |
| 30303536 | From colorectal cancer pattern to the characterization of individuals at risk: Picture for genetic research in Latin America. | Int J Cancer | 2019 |
| 31849974 | Diagnostic Profiling of the Human Public IgM Repertoire With Scalable Mimotope Libraries. | Front Immunol | 2019 |
| 31704995 | PathTracer: High-sensitivity detection of differential pathway activity in tumours. | Sci Rep | 2019 |
| 31442815 | A snapshot of current genetic testing practice in Lynch syndrome: The results of a representative survey of 33 Latin American existing centres/registries. | Eur J Cancer | 2019 |
| 30988515 | Roadmap for a precision-medicine initiative in the Nordic region. | Nat Genet | 2019 |
| 30862609 | Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response. | Cold Spring Harb Mol Case Stud | 2019 |
| 30804006 | Responsiveness to PD-1 Blockade in End-Stage Colon Cancer with Gene Locus 9p24.1 Copy-Number Gain. | Cancer Immunol Res | 2019 |